Sexual dimorphism in a mouse model of Friedreich's ataxia with severe cardiomyopathy

被引:0
作者
Salinas, Lili [1 ]
Montgomery, Claire B. [1 ]
Figueroa, Francisco [1 ]
Thai, Phung N. [2 ,3 ]
Chiamvimonvat, Nipavan [2 ,3 ]
Cortopassi, Gino [1 ]
Dedkova, Elena N. [1 ,4 ]
机构
[1] Univ Calif Davis, Dept Mol Biosci, Davis, CA 95616 USA
[2] Univ Calif Davis, Dept Internal Med, Davis, CA USA
[3] Northern Calif Hlth Care Syst, Dept Vet Affairs, Mather, CA USA
[4] Calif Northstate Univ, Dept Basic Sci, Elk Grove, CA 95757 USA
关键词
DISEASE; HEART; ESTROGEN; PROTEIN; RECEPTOR; STEROIDOGENESIS; OMAVELOXOLONE; TESTOSTERONE; CHOLESTEROL; EXPRESSION;
D O I
10.1038/s42003-024-06962-4
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Friedreich's ataxia (FA) is an autosomal recessive disorder caused by reduced frataxin (FXN) expression in mitochondria, where the lethal component is cardiomyopathy. Using the conditional Fxnflox/null::MCK-Cre knock-out (Fxn-cKO) mouse model, we discovered significant sex differences in the progression towards heart failure, with Fxn-cKO males exhibiting a worse cardiac phenotype, low survival rate, kidney and reproductive organ deficiencies. These differences are likely due to a decline in testosterone in Fxn-cKO males. The decrease in testosterone was related to decreased expression of proteins involved in cholesterol transfer into the mitochondria: StAR and TSPO on the outer mitochondrial membrane, and the cholesterol side-chain cleavage enzyme P450scc and ferredoxin on the inner mitochondrial membrane. Expression of excitation-contraction coupling proteins (L-type calcium channel, RyR2, SERCA2, phospholamban and CaMKII delta) was decreased significantly more in Fxn-cKO males. This is the first study that extensively investigates the sexual dimorphism in FA mouse model with cardiac calcium signaling impairment. Sexual dimorphism is identified in a mouse model of Friedreich's ataxia, with males exhibiting a worse cardiac phenotype, low survival rate, as well as kidney and reproductive organ deficiencies.
引用
收藏
页数:15
相关论文
共 50 条
  • [31] Circulating miR-323-3p is a biomarker for cardiomyopathy and an indicator of phenotypic variability in Friedreich's ataxia patients
    Seco-Cervera, M.
    Gonzalez-Rodriguez, D.
    Ibanez-Cabellos, J. S.
    Peiro-Chova, L.
    Gonzalez-Cabo, P.
    Garcia-Lopez, E.
    Vilchez, J. J.
    Sanz-Gallego, I.
    Pallardo, F. V.
    Garcia-Gimenez, J. L.
    SCIENTIFIC REPORTS, 2017, 7
  • [32] Impaired myocardial perfusion reserve and fibrosis in Friedreich ataxia: a mitochondrial cardiomyopathy with metabolic syndrome
    Raman, Subha V.
    Phatak, Kavita
    Hoyle, J. Chad
    Pennell, Michael L.
    McCarthy, Beth
    Tran, Tam
    Prior, Thomas W.
    Olesik, John W.
    Lutton, Anthony
    Rankin, Chelsea
    Kissel, John T.
    al-Dahhak, Roula
    EUROPEAN HEART JOURNAL, 2011, 32 (05) : 561 - 567
  • [33] Finding an Appropriate Mouse Model to Study the Impact of a Treatment for Friedreich Ataxia on the Behavioral Phenotype
    Bouchard, Camille
    Gerard, Catherine
    Yanyabe, Solange Gni-fiene
    Majeau, Nathalie
    Aloui, Malek
    Buisson, Gabrielle
    Yameogo, Pouire
    Couture, Vanessa
    Tremblay, Jacques P.
    GENES, 2023, 14 (08)
  • [34] Epoetin Alfa Increases Frataxin Production in Friedreich's Ataxia Without Affecting Hematocrit
    Sacca, Francesco
    Piro, Raffaele
    De Michele, Giuseppe
    Acquaviva, Fabio
    Antenora, Antonella
    Carlomagno, Guido
    Cocozza, Sergio
    Denaro, Alessandra
    Guacci, Anna
    Marsili, Angela
    Perrotta, Gaetano
    Puorro, Giorgia
    Cittadini, Antonio
    Filla, Alessandro
    MOVEMENT DISORDERS, 2011, 26 (04) : 739 - 742
  • [35] The ins and outs of mitochondrial iron-loading: the metabolic defect in Friedreich's ataxia
    Richardson, Des R.
    Huang, Michael L-H.
    Whitnall, Megan
    Becker, Erika M.
    Ponka, Prem
    Rahmanto, Yohan Suryo
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2010, 88 (04): : 323 - 329
  • [36] Predictors of Survival in Friedreich's Ataxia: A Prospective Cohort Study
    Indelicato, Elisabetta
    Reetz, Kathrin
    Maier, Sarah
    Nachbauer, Wolfgang
    Amprosi, Matthias
    Giunti, Paola
    Mariotti, Caterina
    Durr, Alexandra
    Garrido, Francisco J. R. de Rivera
    Klopstock, Thomas
    Schoels, Ludger
    Klockgether, Thomas
    Buerk, Katrin
    Pandolfo, Massimo
    Didszun, Claire
    Grobe-Einsler, Marcus
    Nanetti, Lorenzo
    Nenning, Lukas
    Kiechl, Stefan
    Dichtl, Wolfgang
    Ulmer, Hanno
    Schulz, Joerg B.
    Boesch, Sylvia
    MOVEMENT DISORDERS, 2024, 39 (03) : 510 - 518
  • [37] The role of oxidative stress in Friedreich's ataxia
    Lupoli, Federica
    Vannocci, Tommaso
    Longo, Giovanni
    Niccolai, Neri
    Pastore, Annalisa
    FEBS LETTERS, 2018, 592 (05) : 718 - 727
  • [38] The dynamin-related protein 1 is decreased and the mitochondrial network is altered in Friedreich's ataxia cardiomyopathy
    Chidipi, Bojjibabu
    Angulo, Mariana Burgos
    Shah, Syed Islamuddin
    Rieser, Michelle
    Ullah, Ganim
    McDonald, Thomas, V
    Noujaim, Sami F.
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2022, 143
  • [39] Reverse Phase Protein Array Reveals Correlation of Retinoic Acid Metabolism With Cardiomyopathy in Friedreich's Ataxia
    Napierala, Jill S.
    Rajapakshe, Kimal
    Clark, Amanda
    Chen, Yu-Yun
    Huang, Shixia
    Mesaros, Clementina
    Xu, Peining
    Blair, Ian A.
    Hauser, Lauren A.
    Farmer, Jennifer
    Lynch, David R.
    Edwards, Dean P.
    Coarfa, Cristian
    Napierala, Marek
    MOLECULAR & CELLULAR PROTEOMICS, 2021, 20
  • [40] Effects of tocotrienol supplementation in Friedreich's ataxia: A model of oxidative stress pathology
    Bolotta, Alessandra
    Pini, Antonella
    Abruzzo, Provvidenza M.
    Ghezzo, Alessandro
    Modesti, Alessandra
    Gamberi, Tania
    Ferreri, Carla
    Bugamelli, Francesca
    Fortuna, Filippo
    Vertuani, Silvia
    Manfredini, Stefano
    Zucchini, Cinzia
    Marini, Marina
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2020, 245 (03) : 201 - 212